北京大学学报(医学版) ›› 2022, Vol. 54 ›› Issue (4): 621-627. doi: 10.19723/j.issn.1671-167X.2022.04.007
李志华1,2,徐纯如1,刘颖1,2,贯华1,2,张萌1,2,车新艳1,2,唐琦1,黄燕波1,2,*(),李学松1,*(
),周利群1
Zhi-hua LI1,2,Chun-ru XU1,Yin LIU1,2,Hua GUAN1,2,Meng ZHANG1,2,Xin-yan CHE1,2,Qi TANG1,Yan-bo HUANG1,2,*(),Xue-song LI1,*(
),Li-qun HOU1
摘要:
目的: 探究饮水习惯与上尿路尿路上皮癌(upper tract urothelial carcinoma, UTUC)患者的临床病理特征之间的相关性。方法: 选取北京大学第一医院泌尿外科2020年8月至2021年7月收治的拟行根治性切除术的UTUC患者,在术前进行问卷调查,了解其饮水习惯,结合其术后病理特点进行统计分析。统计过程采用SPSS 22.0软件,首先采用列联表χ2检验,对UTUC肿瘤病理特点作为因变量与患者一般信息、既往史及饮水习惯相关因素等作为自变量逐一进行初步分析,筛选出针对各因变量病例组和对照组之间满足P<0.2的自变量,将筛选后的变量纳入二元Logistic回归分析,以P<0.05为差异有统计学意义。结果: 共纳入239例患者,男性134例,女性105例,平均年龄(68.1±9.98)岁,中位病程4.8个月。统计结果提示,经调整了混杂因素的影响后,有白天每小时至少饮水1次习惯的UTUC患者患高级别(G3)肿瘤的概率增加(OR=1.941, 95%CI: 0.352~1.029,P<0.01);有白天每小时至少饮水1次习惯的患者相对于没有这一习惯的患者患多灶性UTUC肿瘤的发病风险显著下降(OR=0.344, 95%CI: 1.18~5.582,P=0.004),同时有每次饮水≥100 mL习惯的患者相对于无这一习惯者多灶性UTUC肿瘤的发病风险也显著下降(OR=0.477, 95%CI: 0.225~1.012,P=0.046);有自我关注每日饮水这一习惯的患者相对于无这一习惯的患者患肾盂癌的风险显著升高(OR=2.530, 95%CI: 1.434~4.463,P=0.001),而患输尿管癌的风险显著降低(OR=0.314, 95%CI: 0.172~0.573,P<0.01);其他纳入回归模型的变量对肿瘤病理特点发生的影响差异无统计学意义。结论: 有白天每小时至少饮水1次、每次饮水≥100 mL、自我关注每日饮水等饮水习惯分别与上尿路尿路上皮癌病理特点(如肿瘤G3、肿瘤多灶性及肿瘤位于肾盂或输尿管)存在显著相关性,这一结论仍需后续更高证据等级的试验加以验证。
中图分类号:
1 |
Siegel RL , Miller KD , Jemal A , et al. Cancer statistics, 2019[J]. CA Cancer J Clin, 2019, 69 (1): 7- 34.
doi: 10.3322/caac.21551 |
2 |
Audenet F , Isharwal S , Cha EK , et al. Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma[J]. Clin Cancer Res, 2019, 25 (3): 967- 976.
doi: 10.1158/1078-0432.CCR-18-2039 |
3 |
Zamboni S , Foerster B , Abufaraj M , et al. Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy[J]. BJU Int, 2019, 124 (5): 738- 745.
doi: 10.1111/bju.14751 |
4 |
Belhadj Y , Grande P , Seisen T , et al. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothe-lial carcinoma and its influence on oncological outcomes[J]. BJU Int, 2019, 123 (4): 618- 623.
doi: 10.1111/bju.14647 |
5 |
Scott AM , Clark J , Mar CD , et al. Increased fluid intake to prevent urinary tract infections: systematic review and meta-analysis[J]. Br J Gen Pract, 2020, 70 (692): e200- e207.
doi: 10.3399/bjgp20X708125 |
6 | 卢海梅. 饮食饮水习惯女性泌尿系结石复发的前瞻性研究[J]. 实用临床护理学电子杂志, 2020, 5 (15): 94. |
7 |
Bai Y , Yuan H , Li J , et al. Relationship between bladder cancer and total fluid intake: a meta-analysis of epidemiological evidence[J]. World J Surg Oncol, 2014, 12, 223.
doi: 10.1186/1477-7819-12-223 |
8 |
Hong X , Xu Q , Lan K , et al. The effect of daily fluid management and beverages consumption on the risk of bladder cancer: a meta-analysis of observational atudy[J]. Nutr Cancer, 2018, 70 (8): 1217- 1227.
doi: 10.1080/01635581.2018.1512636 |
9 |
李金蓉, 蒙有轩, 廖君娟, 等. 泌尿系结石复发病人饮水习惯调查[J]. 护理研究, 2017, 31 (36): 4691- 4693.
doi: 10.3969/j.issn.1009-6493.2017.36.030 |
10 |
Collà Ruvolo C , Nocera L , Stolzenbach LF , et al. Incidence and survival rates of contemporary patients with invasive upper tract urothelial carcinoma[J]. Eur Urol Oncol, 2021, 4 (5): 792- 801.
doi: 10.1016/j.euo.2020.11.005 |
11 | 周利群, 熊耕砚, 李学松. 中国人群上尿路尿路上皮癌诊疗策略选择和东西方差异[J]. 临床泌尿外科杂志, 2019, 34 (2): 83- 87. |
12 |
方冬, 黄吉炜, 鲍一歌, 等. 中国上尿路尿路上皮癌人群特征和地区差异: 基于CUDA-UTUC协作组的多中心研究[J]. 中华泌尿外科杂志, 2017, 38 (12): 885- 890.
doi: 10.3760/cma.j.issn.1000-6702.2017.12.002 |
13 | 张宁, 崔剑锋, 李岩, 等. 上尿路尿路上皮癌预后生物标志物的研究进展[J]. 临床泌尿外科杂志, 2019, 34 (2): 119- 123. |
14 |
Rolim I , Henriques V , Rolim N , et al. Clinicopathologic analysis of upper urinary tract carcinoma with variant histology[J]. Virchows Arch, 2020, 477 (1): 111- 120.
doi: 10.1007/s00428-020-02745-4 |
15 | 陈晗, 王明, 任轲, 刘苑, 等. 不同分期上尿路尿路上皮癌患者预后分析[J]. 临床泌尿外科杂志, 2021, 36 (5): 357- 361. |
16 | 陈金虎, 方卫华, 梁朝朝. 上尿路尿路上皮癌临床治疗进展[J]. 临床泌尿外科杂志, 2021, 36 (5): 415- 420. |
17 |
Martin C , Leiser CL , O'Neil B , et al. Familial cancer clustering in urothelial cancer: a population-based case-control study[J]. J Natl Cancer Inst, 2018, 110 (5): 527- 533.
doi: 10.1093/jnci/djx237 |
18 |
曹振朋, 关豹, 方冬, 等. 年轻上尿路尿路上皮癌患者的临床病理和预后特征[J]. 现代泌尿外科杂志, 2017, 22 (9): 661- 665.
doi: 10.3969/j.issn.1009-8291.2017.09.004 |
19 |
Han J , Xian Z , Zhang Y , et al. Systematic overview of aristo-lochic acids: nephrotoxicity, carcinogenicity, and underlying mechanisms[J]. Front Pharmacol, 2019, 10, 648.
doi: 10.3389/fphar.2019.00648 |
20 | Simon D , Yen S , Cole P . Coffee-drinking and cancer of the lower urinary tract[J]. J Natl Cancer Inst, 1975, 54 (3): 587- 591. |
21 | Morgan RW , Jain MG . Bladder cancer: smoking, beverages and artificial sweeteners[J]. Can Med Assoc J, 1974, 111 (10): 1067- 1070. |
22 |
Jensen OM , Wahrendorf J , Knudsen JB , et al. The Copenhagen case-control study of bladder cancer. Ⅱ. Effect of coffee and other beverages[J]. Int J Can-cer, 1986, 37 (5): 651- 657.
doi: 10.1002/ijc.2910370503 |
23 |
Silverman DT , Alguacil J , Rothman N , et al. Does increased urination frequency protect against bladder cancer?[J]. Int J Can-cer, 2008, 123 (7): 1644- 1648.
doi: 10.1002/ijc.23572 |
24 | Zhou J , Smith S , Giovannucci E , et al. Reexamination of total fluid intake and bladder cancer in the Health Professionals Follow-up Study Cohort[J]. Am J Epidemiol, 2012, 175 (7): 696- 705. |
25 | van Hensbergen M , van Osch FHM , Jochems S , et al. Fluid intake and clinicopathological characteristics of bladder cancer: the west midlands bladder cancer prognosis programme[J]. Eur J Cancer Prev, 2020, 29 (2): 110- 118. |
26 | Wang J , Wu X , Kamat A , et al. Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer risk[J]. Br J Cancer, 2013, 108 (11): 2372- 2380. |
27 | Jochems SHJ , van Osch FHM , Reulen RC , et al. Total fluid intake and the risk of recurrence in patients with muscle invasive bladder cancer: a prospective cohort study[J]. Bladder Cancer, 2018, 4 (3): 303- 310. |
28 | Sfakianos JP , Gul Z , Shariat SF , et al. Genetic differences between bladder and upper urinary tract carcinoma: implications for therapy[J]. Eur Urol Oncol, 2021, 4 (2): 170- 179. |
[1] | 刘帅,刘磊,刘茁,张帆,马潞林,田晓军,侯小飞,王国良,赵磊,张树栋. 伴静脉癌栓的肾上腺皮质癌的临床治疗及预后[J]. 北京大学学报(医学版), 2024, 56(4): 624-630. |
[2] | 姚中强,李常虹,李欣艺,郭苇,翟佳羽,刘蕊,魏慧,穆荣. 抗磷脂酰丝氨酸/凝血酶原抗体与不明原因复发性流产的相关性分析[J]. 北京大学学报(医学版), 2023, 55(6): 1058-1061. |
[3] | 薛子璇,唐世英,邱敏,刘承,田晓军,陆敏,董靖晗,马潞林,张树栋. 青年肾肿瘤伴瘤栓的临床病理特征及预后分析[J]. 北京大学学报(医学版), 2023, 55(5): 802-811. |
[4] | 赖玉梅,李忠武,李欢,吴艳,时云飞,周立新,楼雨彤,崔传亮. 68例肛管直肠黏膜黑色素瘤临床病理特征及预后[J]. 北京大学学报(医学版), 2023, 55(2): 262-269. |
[5] | 朱晓娟,张虹,张爽,李东,李鑫,徐玲,李挺. 人表皮生长因子受体2低表达乳腺癌的临床病理学特征及预后[J]. 北京大学学报(医学版), 2023, 55(2): 243-253. |
[6] | 郭玉兴,张建运,王佃灿,郭传瑸. 药物相关颌骨骨坏死的病理特点及临床治疗策略[J]. 北京大学学报(医学版), 2022, 54(6): 1190-1195. |
[7] | 戴翔,王飞,杜依青,宋宇轩,徐涛. 上尿路尿路上皮癌组织中脂肪因子表达与临床病理特征及预后的相关性[J]. 北京大学学报(医学版), 2022, 54(4): 605-614. |
[8] | 张崔建,何志嵩,周利群. 上尿路尿路上皮癌的淋巴清扫[J]. 北京大学学报(医学版), 2022, 54(4): 592-594. |
[9] | 丁婷婷,曾楚雄,胡丽娜,余明华. 基于癌症基因组图谱数据库结直肠癌免疫细胞浸润预测模型的建立[J]. 北京大学学报(医学版), 2022, 54(2): 203-208. |
[10] | 王迎春,黄永辉,常虹,姚炜,闫秀娥,李柯,张耀鹏,郑炜. 十二指肠乳头息肉良、恶性病变比较及活检准确性[J]. 北京大学学报(医学版), 2021, 53(1): 204-209. |
[11] | 王文鹏,王捷夫,胡均,王俊锋,刘嘉,孔大陆,李健. 结直肠间质瘤临床病理特征及预后分析[J]. 北京大学学报(医学版), 2020, 52(2): 353-361. |
[12] | 关豹,翁迈,凡航,彭鼎,方冬,熊耕砚,李学松,周利群. 术前贫血对上尿路尿路上皮癌预后的影响: 单中心686例患者回顾性研究[J]. 北京大学学报(医学版), 2019, 51(6): 1056-1061. |
[13] | 马闰卓,夏海缀,陆敏,张智荧,张启鸣,卢剑,王国良,马潞林. 输尿管镜活体组织检查对上尿路尿路上皮癌根治性手术的影响[J]. 北京大学学报(医学版), 2019, 51(4): 665-672. |
[14] | 张晓鹏,黄子雄,于路平,张晓威,李清,刘士军,徐涛. 小肾细胞癌的临床与病理特征分析[J]. 北京大学学报(医学版), 2019, 51(4): 623-627. |
[15] | 杨阳,刘毅强,王晓红,季科,李忠武,白健,杨爱蓉,胡颖,韩海勃,李子禹,步召德,吴晓江,张连海,季加孚. 单中心大样本Epstein-Barr病毒相关性胃癌亚型的临床病理及分子特征分析[J]. 北京大学学报(医学版), 2019, 51(3): 451-458. |
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 142
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 565
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Cited |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Shared | ||||||||||||||||||||||||||||||||||||||||||||||||||
Discussed |
|